4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001437749-16-034203
Chief Financial Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arrow Alexander K. Chief Financial Officer | 2016-06-17 | Grant or award | +140,000 | $1.25 | $175,000 | 358,260 | D |
Loading xslF345X03/rdgdoc.xml…